The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells.
Open accessAbstract
We have used polyclonal anti-synthetic peptide serum to study the role of retinoblastoma gene (RB) inactivation in a variety of human tumor cell lines. Our analysis indicates that inactivation of the RB protein, p105-Rb, is universal in retinoblastoma cells, vindicating the predictions of the Knudson "two-hit" hypothesis. In addition, our analysis has shown that inactivations of the RB gene are nearly as frequent in a more common human tumor, small cell lung carcinoma. One-third of bladder carcinomas surveyed also carry altered or absent p105-Rb. Other human tumors by contrast demonstrate only infrequent inactivation of the RB gene. These results suggest that inactivation of the RB gene is a critical step in the pathogenesis of a subset of human tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Organization and Expression of Eucaryotic Split Genes Coding for Proteins
Breathnach, R., & Chambon, P. (1981) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.50.070181.002025 · Cited by 4,548
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948
Self-citationExpression of recessive alleles by chromosomal mechanisms in retinoblastoma
Cavenee, W. K., Dryja, T. P., Phillips, R. A., Benedict, W. F., Godbout, R., Gallie, B. L., Murphree, A. L., Strong, L. C., & White, R. L. (1983) · Nature · doi:10.1038/305779a0 · Cited by 1,920
Self-citationVariable Number of Tandem Repeat (VNTR) Markers for Human Gene Mapping
Nakamura, Y., Leppert, M., O'Connell, P., Wolff, R., Holm, T., Culver, M., Martin, C., Fujimoto, E., Hoff, M., Kumlin, E., et al. (1987) · Science · doi:10.1126/science.3029872 · Cited by 1,654
DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459
Human Retinoblastoma Susceptibility Gene: Cloning, Identification, and Sequence
Lee, W.-H., Bookstein, R., Hong, F., Young, L.-J., Shew, J.-Y., & Lee, E. Y.-H. P. (1987) · Science · doi:10.1126/science.3823889 · Cited by 1,417
Cited by
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Comprehensive genomic profiles of small cell lung cancer
George, J., Lim, J. S., Jang, S. J., Cun, Y., Ozretić, L., Kong, G., Leenders, F., Lu, X., Fernández-Cuesta, L., Bosco, G., et al. (2015) · Nature · doi:10.1038/nature14664 · Cited by 2,340
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,756
Self-citationMolecular themes in oncogenesis
Bishop, J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90636-d · Cited by 1,637
The E2F transcription factor is a cellular target for the RB protein
Chellappan, S. P., Hiebert, S., Mudryj, M., Horowitz, J. M., & Nevins, J. R. (1991) · Cell · doi:10.1016/0092-8674(91)90557-f · Cited by 1,412
Self-citationIntegrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Peifer, M., Fernández-Cuesta, L., Sos, M. L., George, J., Seidel, D., Kasper, L. H., Plenker, D., Leenders, F., Sun, R., Zander, T., et al. (2012) · Nature Genetics · doi:10.1038/ng.2396 · Cited by 1,397
Stott, F. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5001 · Cited by 1,167
The Rb/E2F pathway: expanding roles and emerging paradigms
Harbour, J. W., & Dean, D. C. (2000) · Genes & Development · doi:10.1101/gad.813200 · Cited by 1,153
Human Cyclin E, a Nuclear Protein Essential for the G1-to-S Phase Transition
Ohtsubo, M., Theodoras, A. M., Schumacher, J., Roberts, J. M., & Pagano, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2612 · Cited by 1,148
A small-cell lung cancer genome with complex signatures of tobacco exposure
Pleasance, E. D., Stephens, P. J., O’Meara, S., McBride, D. J., Meynert, A., Jones, D., Lin, M.-L., Beare, D., Lau, K. W., Greenman, C., et al. (2010) · Nature · doi:10.1038/nature08629 · Cited by 1,066
Self-citationRegulation of retinoblastoma protein functions by ectopic expression of human cyclins
Hinds, P. W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S. I., & Weinberg, R. A. (1992) · Cell · doi:10.1016/0092-8674(92)90249-c · Cited by 995
Self-citationGaidano, G., Ballerini, P., Gong, J. Z., Inghirami, G., Neri, A., Newcomb, E. W., Magrath, I. T., Knowles, D. M., & Dalla-Favera, R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5413 · Cited by 885
Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples
Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., et al. (1991) · Science · doi:10.1126/science.2024123 · Cited by 875
The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.
Scheffner, M., Münger, K., Byrne, J. C., & Howley, P. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5523 · Cited by 849
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties
Kaelin, W. G., Krek, W., Sellers, W. R., DeCaprio, J. A., Ajchenbaum, F., Fuchs, C. S., Chittenden, T., Li, Y., Farnham, P. J., Blanar, M. A., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90108-o · Cited by 819
Marshall, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90641-b · Cited by 751
Physical interaction of the retinoblastoma protein with human D cyclins
Dowdy, S. F., Hinds, P. W., Louie, K., Reed, S. I., Arnold, A., & Weinberg, R. A. (1993) · Cell · doi:10.1016/0092-8674(93)90137-f · Cited by 744
Self-citationGu, W., Schneider, J. W., Condorelli, G., Kaushal, S., Mahdavi, V., & Nadal-Ginard, B. (1993) · Cell · doi:10.1016/0092-8674(93)90110-c · Cited by 729
The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle
Goodrich, D. W., Wang, N. P., Qian, Y.-W., Lee, E. Y.-H. P., & Lee, W.-H. (1991) · Cell · doi:10.1016/0092-8674(91)90181-w · Cited by 707
Hsp90 inhibitors as novel cancer chemotherapeutic agents
Neckers, L. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02316-x · Cited by 677
Chellappan, S., Kraus, V. B., Kroger, B., Munger, K., Howley, P. M., Phelps, W. C., & Nevins, J. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4549 · Cited by 614
A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F
Helin, K., Lees, J. A., Vidal, M., Dyson, N., Harlow, E., & Fattaey, A. (1992) · Cell · doi:10.1016/0092-8674(92)90107-n · Cited by 613
Gelbert, L. M., Cai, S., Lin, X., Sanchez-Martinez, C., del Prado, M., Lallena, M. J., Torres, R., Ajamie, R. T., Wishart, G. N., Flack, R. S., et al. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0120-7 · Cited by 577
The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.
Hiebert, S. W., Chellappan, S. P., Horowitz, J. M., & Nevins, J. R. (1992) · Genes & Development · doi:10.1101/gad.6.2.177 · Cited by 576
Self-citationCancer Incidence After Retinoblastoma: Radiation Dose and Sarcoma Risk
Wong, F. L. (1997) · JAMA · doi:10.1001/jama.1997.03550150066037 · Cited by 486
Kaelin, W. G., Pallas, D. C., DeCaprio, J. A., Kaye, F. J., & Livingston, D. M. (1991) · Cell · doi:10.1016/0092-8674(91)90236-r · Cited by 518
Self-citationInhibition of cell proliferation by p107, a relative of the retinoblastoma protein.
Zhu, L., van den Heuvel, S., Helin, K., Fattaey, A., Ewen, M., Livingston, D., Dyson, N., & Harlow, E. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1111 · Cited by 514
Rb function in cell-cycle regulation and apoptosis
Harbour, J. W., & Dean, D. C. (2000) · Nature Cell Biology · doi:10.1038/35008695 · Cited by 509
Kleinerman, R. A., Tucker, M. A., Tarone, R. E., Abramson, D. H., Seddon, J. M., Stovall, M., Li, F. P., & Fraumeni, J. F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.054 · Cited by 487
Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein.
Helin, K., Harlow, E., & Fattaey, A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6501 · Cited by 472
Bagchi, S., Weinmann, R., & Raychaudhuri, P. (1991) · Cell · doi:10.1016/0092-8674(91)90558-g · Cited by 426
Dannenberg, J.-H., van Rossum, A., Schuijff, L., & te Riele, H. (2000) · Genes & Development · doi:10.1101/gad.847700 · Cited by 413
Chittenden, T., Livingston, D. M., & Kaelin, W. G. (1991) · Cell · doi:10.1016/0092-8674(91)90559-h · Cited by 407
Identification of a growth suppression domain within the retinoblastoma gene product.
Qin, X. Q., Chittenden, T., Livingston, D. M., & Kaelin, W. G. (1992) · Genes & Development · doi:10.1101/gad.6.6.953 · Cited by 404
Cell cycle regulation of the human cdc2 gene.
Dalton, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05231.x · Cited by 381
Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer.
Jiang, W., Zhang, Y. J., Kahn, S. M., Hollstein, M. C., Santella, R. M., Lu, S. H., Harris, C. C., Montesano, R., & Weinstein, I. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9026 · Cited by 360
Khleif, S. N., DeGregori, J., Yee, C. L., Otterson, G. A., Kaye, F. J., Nevins, J. R., & Howley, P. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4350 · Cited by 358
Self-citationTailoring to RB: tumour suppressor status and therapeutic response
Knudsen, E. S., & Knudsen, K. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2401 · Cited by 344
The retinoblastoma protein is phosphorylated on multiple sites by human cdc2.
Lees, J. A., Buchkovich, K. J., Marshak, D. R., Anderson, C. W., & Harlow, E. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb05006.x · Cited by 337
Targeted disruption of p107: functional overlap between p107 and Rb.
Lee, M. H., Williams, B. O., Mulligan, G., Mukai, S., Bronson, R. T., Dyson, N., Harlow, E., & Jacks, T. (1996) · Genes & Development · doi:10.1101/gad.10.13.1621 · Cited by 336
Deletions of the Short Arm of Chromosome 3 in Solid Tumors and the Search for Suppressor Genes
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60096-2 · Cited by 335
E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle.
Sardet, C., Vidal, M., Cobrinik, D., Geng, Y., Onufryk, C., Chen, A., & Weinberg, R. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2403 · Cited by 335
Self-citationPromoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma.
Bookstein, R., Rio, P., Madreperla, S. A., Hong, F., Allred, C., Grizzle, W. E., & Lee, W. H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7762 · Cited by 334
p107 is a suppressor of retinoblastoma development in pRb-deficient mice
Robanus-Maandag, E., Dekker, M., van der Valk, M., Carrozza, M.-L., Jeanny, J.-C., Dannenberg, J.-H., Berns, A., & te Riele, H. (1998) · Genes & Development · doi:10.1101/gad.12.11.1599 · Cited by 320
Lifetime Risks of Common Cancers Among Retinoblastoma Survivors
Fletcher, O., Easton, D., Anderson, K., Gilham, C., Jay, M., & Peto, J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh058 · Cited by 312
Mittnacht, S., & Weinberg, R. A. (1991) · Cell · doi:10.1016/0092-8674(91)90456-9 · Cited by 311
Self-citationLoss of The Retinoblastoma Tumor-Suppressor Gene in Parathyroid Carcinoma
Cryns, V. L., Thor, A., Xu, H.-J., Hu, S.-X., Wierman, M. E., Vickery, A. L., Benedict, W. F., & Arnold, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403173301105 · Cited by 305
The cell cycle and the retinoblastoma protein family
Ewen, M. E. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00690418 · Cited by 303
Lin, B. T., Gruenwald, S., Morla, A. O., Lee, W. H., & Wang, J. Y. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb08018.x · Cited by 298
Progress in understanding the molecular pathogenesis of human lung cancer
Sekido, Y., Fong, K. M., & Minna, J. D. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00010-9 · Cited by 290
Self-citationRisk of Second Malignancies in Survivors of Retinoblastoma: More Than 40 Years of Follow-up
Marees, T., Moll, A. C., Imhof, S. M., de Boer, M. R., Ringens, P. J., & van Leeuwen, F. E. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn394 · Cited by 286
Henley, S. A., & Dick, F. A. (2012) · Cell Division · doi:10.1186/1747-1028-7-10 · Cited by 281
A new component of the transcription factor DRTF1/E2F
Girling, R., Partridge, J. F., Bandara, L. R., Burden, N., Totty, N. F., Hsuan, J. J., & La Thangue, N. B. (1993) · Nature · doi:10.1038/362083a0 · Cited by 276
Lukas, J., Müller, H., Bartkova, J., Spitkovsky, D., Kjerulff, A. A., Jansen-Dürr, P., Strauss, M., & Bartek, J. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.3.625 · Cited by 269
Cell type-specific effects of Rb deletion in the murine retina
MacPherson, D., Sage, J., Kim, T., Ho, D., McLaughlin, M. E., & Jacks, T. (2004) · Genes & Development · doi:10.1101/gad.1203304 · Cited by 222
Kaye, F. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205834 · Cited by 153
“In each of these cases, however, a deletion or missense mutation was localized within the RB functional ‘pocket’ domain and was found to have specifically inactivated the tumor suppressor activity of RB (Horowitz et al., 1990; Kaye et al., 1990).”
BackgroundSelf-citationThe Retinoblastoma Gene Family in Cell Cycle Regulation and Suppression of Tumorigenesis
Dannenberg, J.-H., & te Riele, H. P. J. (2006) · Results and Problems in Cell Differentiation · doi:10.1007/400_002 · Cited by 47
Johnen, G., Rozynek, P., von der Gathen, Y., Bryk, O., Zdrenka, R., Johannes, C., Weber, D. G., Igwilo-Okuefuna, O., Raiko, I., Hippler, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064139 · Cited by 17
“The relative mRNA expression levels of ZEB1, CDH1, KRT17, VIM, TP63, TP53, RB1, and HRAS in T24 have been published before and are basically in agreement with our results [32,34–41].”
Result
Metadata
- Authors
- Horowitz, J. M., Park, S. H., Bogenmann, E., Cheng, J. C., Yandell, D. W., Kaye, F. J., Minna, J. D., Dryja, T. P., & Weinberg, R. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1990-04
- Volume
- 87
- Issue
- 7
- Pages
- 2775-2779
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1980890490
- Cited by
- 530
- References
- 38
- FWCI
- 22.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.